Expert Commentary
View AllPublications
Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
The role of core strengthening for chronic low back pain.
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
Buckley DI, Calvert JF, Lapidus JA, et al.
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Garven A, Brady S, Wood S, Hatfield M, Bestard J, Korngut L, Toth C.
Pain Res Manag. 2011...
Pain Res Manag. 2011...
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.
J Addict...
J Addict...
The role of core strengthening for chronic low back pain.
Akuthota V, Standaert CJ, Chimes GP.
PM R. 2011 Jul;3(7):664-70.
PM R. 2011 Jul;3(7):664-70.
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
Beck JG, Clapp JD.
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...







Usefulness of Prescription Monitoring Programs for Surveillance—Analysis of Schedule II Opioid Prescription Data in Massachusetts, 1996–2006
Nathaniel Katz, MD, MS
Tufts University School of Medicine
Boston, MA
Clinicians who treat pain must balance the powerful analgesic profile of opioids with the growing problems of nonmedical use and diversion. Several tools have been developed to promote safe opioid prescribing. For example, most US states have implemented or are in the process of implementing prescription monitoring programs (PMPs). The Massachusetts PMP tracks prescriptions of all Schedule II drugs, which includes most opioids. Dr Katz and colleagues analyzed 11 years (1996-2006) of Massachusetts PMP data to identify trends in opioid prescribing, dispensing, and usage. A general increase in opioid prescribing was noted over the analyzed period. The authors also examined questionable activity, which was defined as the use of >4 prescribers and >4 pharmacies, suggesting that the patient was ‘doctor shopping.’ Among all opioid prescriptions in the dataset, questionable activity was observed for 0.5% of individuals, 3.1% of prescriptions, and 3.1% of dosage units. Among the various opioids, short-acting oxycodone was most strongly associated with questionable activity. This data highlights the utility of PMPs for monitoring medical and nonmedical use of prescription opioids.
References